News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
10
2025
-
04
Endogenous transformation, opening up new situations! Keyuan Pharmaceutical & Linyi Pharmaceutical appeared at the 2025 Wuzhen Health Conference!
Classification：
行业新闻
Corporate News
In April, Wuzhen, with its white walls and grey tiles, exudes vibrant life. The 2025 Wuzhen Health Conference opened its curtain in this ink-and-wash painting.
4 On May 9th, the 2025 Wuzhen Health Conference and the 4th OTC Conference opened as scheduled. Themed "To Spring: Endogenous and Exogenous Changes in a Changing Situation," the conference brought together China's rich health industry ecosystem resources to create a benchmark for high-quality innovative development of China's health industry. Koyuan Pharmaceutical (Stock Code: 301281.SZ) & Linoa Pharmaceutical showcased several new products and a series of health solutions, attracting widespread attention from the industry.
Endogenous Transformation, Innovation Drives Product Upgrades
The W at the main entrance of the main venue 03 The booth was bustling with people, the atmosphere was enthusiastic, and many attendees and industry partners stopped to visit. The Koyuan Pharmaceutical & Linoa Pharmaceutical marketing team interacted and exchanged ideas with new and old friends from all over the country, discussing cooperation.
In this exhibition and conference, Linoa Pharmaceutical showcased its core classic products in the cardiovascular, hypoglycemic, and central nervous system fields. At the same time, it launched a series of new products—the OTC Class A product "Ferric Protein Succinate Oral Solution" for the treatment of iron deficiency anemia, and "Ambroxol Hydrochloride Droplets" for children's cough. Many new and old partners showed strong interest in the company's new products and expressed their willingness to cooperate deeply, laying a solid foundation for the company to expand its market and deepen its industrial layout.
For a long time, the company has attached great importance to product research and development and introduction, investing a large amount of resources to build a complete retail product line, aiming to provide industry partners and consumers with better and safer health solutions. The debut of these new products is a powerful demonstration of the company's strengthened product strength and the gradual improvement of its product matrix.
Expanding New Markets, Open Cooperation for a Win-Win Future
Inside the booth, a series of products won widespread cooperation. Outside the booth, the company's Strength gained a reputation for honor.
The company team actively participated in various forums and exchange activities during the conference, discussing new trends and opportunities in the pharmaceutical industry with colleagues in the industry.
Faced with a complex and changing market environment and increasingly fierce competition, going it alone is no longer suitable for the current industry development situation. Koyuan Pharmaceutical & Linoa Pharmaceutical always adheres to the cooperation philosophy of "openness, unity, and win-win." Through endogenous transformation, it continuously strengthens internal management, improves technological research and development capabilities, and optimizes product quality; it expands new markets, utilizes various industry platforms, strengthens cooperation and exchanges with upstream and downstream enterprises, integrates high-quality resources, and jointly promotes the innovative development of the pharmaceutical industry.
Major New Products, Win Major Honors at the Conference
4 On the evening of May 8th, the conference organizing committee released the annual product list—"West Lake Award - The Most Popular Star Single Product in Retail Pharmacies." The company's new product, "Ambroxol Hydrochloride Droplets," was honorably listed.
"Ambroxol Hydrochloride Droplets" is an OTC Class A product that has passed the consistency evaluation of generic drugs. With its unique dosage form, precise medication, and good compliance, it has won the favor and recommendation of many clinical guideline consensuses and is an important product for Linoa Pharmaceutical to optimize its retail product line.
April in the world, the most beautiful is Jiangnan. Koyuan Pharmaceutical & Linoa Pharmaceutical sincerely invite you to visit Wuzhen, and together with us, use technology as a link and quality as the cornerstone, work together with industry chain partners to create ecological value, share development opportunities, and write a chapter of collaborative development in the pharmaceutical and health field.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
